31.27 USD
↘ 0.02 (0.06%)AT CLOSE (11:59 AM EDT)
Catalyst Pharmaceutical Inc.
CPRXNASDAQ • USD
31.28
↗ 0.01 (0.03%)
POST MARKET (AS OF 07:54 PM EDT)
Post Market
AS OF 07:54 PM EDT
31.28
↗ 0.01 (0.03%)
Market: CLOSED
Open?$31.29
High?$31.30
Low?$31.27
Prev. Close?$31.29
Volume?1.5M
Avg. Volume?3.0M
VWAP?$31.28
Rel. Volume?0.51x
Bid / Ask
Bid?$31.26 × 1.0K
Ask?$31.32 × 100
Spread?$0.06
Midpoint?$31.29
Valuation & Ratios
Market Cap?3.8B
Shares Out?122.4M
Float?114.3M
Float %?93.0%
P/E Ratio?17.29
P/B Ratio?3.78
EPS?$1.81
Dividend?0.00%
Ex-Dividend?N/A
CPRX is currently priced at $31.27. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, exceptional Return on Equity (21.9%), a bullish Golden Cross on the moving averages and bullish moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
Employees
182
Market Cap
3.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2006-11-08
Address
355 ALHAMBRA CIRCLE
CORAL GABLES, FL 33134
Phone: (305) 529-2522
CORAL GABLES, FL 33134
Phone: (305) 529-2522
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?60
Short Sent.?80
Piotroski F-Score?4/9Mixed
Altman Z-Score?19.79Safe
Confidence?63%Moderate
Short InterestElevated
Short % of Float?6.04%Elevated
Short Interest?6.9M
Days to Cover?1.9
Free Float114.3M
Avg Daily Volume3.6M
Settlement Date2026-05-15
Financial Health
Current Ratio?7.10Strong
Quick Ratio?6.84Strong
Cash Ratio?5.71Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?17.3CHEAP▾
Peers100
S&P74
P/B?3.78FAIR▾
Peers100
S&P46
P/S?6.41FAIR▾
Peers100
S&P20
P/FCF?18.4CHEAP▾
Peers100
S&P61
EV/EBITDA?10.0CHEAP▾
Peers100
S&P81
EV/Sales?5.14FAIR▾
Peers100
S&P35
Returns & Efficiency
ROE?21.9%STRONG▾
Peers50
S&P70
ROA?19.3%STRONG▾
Peers50
S&P94
Cash Flow & Enterprise
FCF?$208.1M
Enterprise Value?$3.1B
Fundamentals ratios updated end of day